This page is an unofficial LFoD record and is not legal advice. Verify the document against the official source before relying on it.
SB335: relative to collaborative pharmacy practice agreements.
Bill details
Version history, amendments, and roll-call votes were not present in the imported local bill data.
Sponsors
- Suzanne M. Prentiss Senate · Dist 5
- David H. Watters Senate · Dist 4
- Hennessey Senate · Dist 1
- Cindy Rosenwald Senate · Dist 13
- Kevin A. Avard Senate · Dist 12
- Sharon M. Carson Senate · Dist 14
- Bill M. Gannon Senate · Dist 23
- Rebecca Whitley Senate · Dist 15
- Kevin Cavanaugh Senate · Dist 16
- Tom Sherman Senate · Dist 24
- James Murphy House · Graf 12
- Peter Schmidt House · Straf 19
- Gary Merchant House · Sull 4
Topics
Health care Business and labor
Official links
CHAPTER 168
SB 335 - FINAL VERSION
2022 SESSION
22-3083
05/11
SENATE BILL 335
AN ACT relative to collaborative pharmacy practice agreements.
ANALYSIS
This bill provides that a collaborative pharmacy practice agreement is an agreement between a pharmacist and attending practitioner.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
22-3083
05/11
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Two
AN ACT relative to collaborative pharmacy practice agreements.
Be it Enacted by the Senate and House of Representatives in General Court convened:
168:1 Collaborative Pharmacy Practice Agreement. Amend RSA 318:1, XXVII to read as follows:
XXVII. "Collaborative pharmacy practice agreement" means a written and signed specific agreement between a pharmacist[,] and an attending practitioner, [and the patient or patient's authorized representative who has granted his or her informed consent,] that provides for collaborative pharmacy practice for the purpose of medication therapy management for the patient.
168:2 Effective Date. This act shall take effect 60 days after its passage.
Approved: June 07, 2022
Effective Date: August 06, 2022